Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-26 12:54 pm Unchanged | 2024-04-24 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 19.020% | 0 (Unchanged) | Filing History |
| 2024-02-02 6:05 pm Purchase | 2024-01-31 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 22.170% | 2,105,263 (+238.11%) | Filing History |
| 2023-09-11 6:23 pm Purchase | 2023-09-06 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 884,152 12.070% | 884,152 (New Position) | Filing History |
| 2022-02-01 4:00 pm Purchase | 2022-01-24 | 13D | Spectrum Pharmaceuticals, Inc. SPPI | Hanmi Pharmaceutical Co. Ltd. | 15,332,331 8.700% | 15,332,331 (New Position) | Filing History |